GeneDx Holdings Corp. Deferred Income Taxes and Tax Credits
GeneDx Holdings Corp. (WGS) reported Deferred Income Taxes and Tax Credits of $379.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxesAndTaxCredits · last filed 2026-08-03
- GeneDx Holdings Corp. deferred income taxes and tax credits for the quarter ending 2026-06-30 was -$518.00K.
- GeneDx Holdings Corp. deferred income taxes and tax credits for the quarter ending 2026-03-31 was $897.00K, a 100.67% increase year-over-year.
- GeneDx Holdings Corp. deferred income taxes and tax credits for the quarter ending 2025-09-30 was $246.00K.
- GeneDx Holdings Corp. deferred income taxes and tax credits for the quarter ending 2025-06-30 was -$245.00K.
- GeneDx Holdings Corp. deferred income taxes and tax credits for fiscal 2024 was -$343.00K.
- GeneDx Holdings Corp. deferred income taxes and tax credits for fiscal 2023 was -$926.00K.
- GeneDx Holdings Corp. deferred income taxes and tax credits for fiscal 2022 was -$49.12M.
- GeneDx Holdings Corp. deferred income taxes and tax credits for fiscal 2021 was $0.00.
| Period end | Deferred Income Taxes and Tax Credits 3 month | Deferred Income Taxes and Tax Credits 6 month | Deferred Income Taxes and Tax Credits 9 month | Deferred Income Taxes and Tax Credits 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$518.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $379.00K 10-Q · filed 2026-08-03 | ||
| 2026-03-31 | $897.00K 10-Q · filed 2026-05-04 | |||
| 2025-09-30 | $246.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.00K derived: sum of 2 quarters · filed 2026-08-03 | $448.00K 10-Q · filed 2025-10-28 | $424.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | -$245.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $202.00K 10-Q · filed 2026-08-03 | $178.00K derived: sum of 3 quarters · filed 2026-08-03 | $131.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $447.00K 10-Q · filed 2026-05-04 | $423.00K derived: sum of 2 quarters · filed 2026-05-04 | $376.00K derived: sum of 3 quarters · filed 2026-05-04 | $186.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$71.00K derived: sum of 2 quarters · filed 2025-10-28 | -$261.00K derived: sum of 3 quarters · filed 2025-10-28 | -$343.00K 10-K · filed 2025-02-20 |
| 2024-09-30 | -$47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$237.00K derived: sum of 2 quarters · filed 2025-10-28 | -$319.00K 10-Q · filed 2025-10-28 | -$730.00K derived: sum of 4 quarters · filed 2025-10-28 |
| 2024-06-30 | -$190.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$272.00K 10-Q · filed 2025-07-29 | -$683.00K derived: sum of 3 quarters · filed 2025-07-29 | -$855.00K derived: sum of 4 quarters · filed 2025-07-29 |
| 2024-03-31 | -$82.00K 10-Q · filed 2025-04-30 | -$493.00K derived: sum of 2 quarters · filed 2025-04-30 | -$665.00K derived: sum of 3 quarters · filed 2025-04-30 | -$861.00K derived: sum of 4 quarters · filed 2025-04-30 |
| 2023-12-31 | -$411.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$583.00K derived: sum of 2 quarters · filed 2025-02-20 | -$779.00K derived: sum of 3 quarters · filed 2025-02-20 | -$926.00K 10-K · filed 2025-02-20 |
| 2023-09-30 | -$172.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$368.00K derived: sum of 2 quarters · filed 2024-10-29 | -$515.00K 10-Q · filed 2024-10-29 | -$463.00K derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | -$196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | -$343.00K 10-Q · filed 2024-07-30 | -$291.00K derived: sum of 3 quarters · filed 2024-07-30 | -$390.00K derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | -$147.00K 10-Q · filed 2024-04-29 | -$95.00K derived: sum of 2 quarters · filed 2024-04-29 | -$194.00K derived: sum of 3 quarters · filed 2024-04-29 | -$49.27M derived: sum of 4 quarters · filed 2024-04-29 |
| 2022-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$47.00K derived: sum of 2 quarters · filed 2024-02-23 | -$49.12M derived: sum of 3 quarters · filed 2024-02-23 | -$49.12M 10-K · filed 2024-02-23 |
| 2022-09-30 | -$99.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$49.18M derived: sum of 2 quarters · filed 2023-11-03 | -$49.18M 10-Q · filed 2023-11-03 | -$49.18M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | -$49.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$49.08M 10-Q · filed 2023-08-08 | -$49.08M derived: sum of 3 quarters · filed 2023-08-08 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |